5 Best Healthcare Stocks Under $50

4. BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Number of Hedge Fund Holders: 44

Share Price as of July 21: $34.70

Paul Choi at Goldman Sachs maintains a Buy rating and $50 price target on BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares as of July 18.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a biotechnology company working on medicines for genetic diseases. It is based in Palo Alto, California.

Our hedge fund data for the first quarter shows 44 hedge funds long BridgeBio Pharma, Inc. (NASDAQ:BBIO). Their total stake value was $861 million.

Follow Bridgebio Pharma Inc. (NASDAQ:BBIO)